日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts

ASCL1在易感细胞环境中驱动EGFR突变肺癌对奥希替尼的耐药性

Bomiao Hu ,Marc Wiesehöfer ,Fernando J de Miguel ,Zongzhi Liu ,Lok-Hei Chan ,Jungmin Choi ,Mary Ann Melnick ,Anna Arnal Estape ,Zenta Walther ,Dejian Zhao ,Francesc Lopez-Giraldez ,Anna Wurtz ,Guoping Cai ,Rong Fan ,Scott Gettinger ,Andrew Xiao ,Qin Yan ,Robert Homer ,Don X Nguyen ,Katerina Politi

Biomarkers Associated with Beneficial PD-1 Checkpoint Blockade in Non-Small Cell Lung Cancer (NSCLC) Identified Using High-Plex Digital Spatial Profiling

使用高密度数字空间分析识别与非小细胞肺癌 (NSCLC) 中有益的 PD-1 检查点阻断相关的生物标志物

Jon Zugazagoitia, Swati Gupta, Yuting Liu, Kit Fuhrman, Scott Gettinger, Roy S Herbst, Kurt A Schalper, David L Rimm

Pleuropulmonary blastoma-like peritoneal sarcoma: a newly described malignancy associated with biallelic DICER1 pathogenic variation

胸膜肺母细胞瘤样腹膜肉瘤:一种新近发现的与双等位基因DICER1致病变异相关的恶性肿瘤

Schultz, Kris Ann P; Nelson, Alexander; Harris, Anne K; Finch, Mike; Field, Amanda; Jarzembowski, Jason A; Wilhelm, Mercedes; Mize, William; Kreiger, Portia; Conard, Katrina; Walter, Andrew; Olson, Thomas; Mitchell, Sarah; Runco, Daniel V; Bechtel, Allison; Klawinski, Darren; Bradfield, Scott; Gettinger, Katie; Stewart, Douglas R; Messinger, Yoav; Dehner, Louis P; Ashley Hill, D

The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma

EGFR 外显子 19 突变体 L747-A750>P 在肺腺癌中对酪氨酸激酶抑制剂表现出独特的敏感性

Anna Truini #, Jacqueline H Starrett #, Tyler Stewart #, Kumar Ashtekar #, Zenta Walther, Anna Wurtz, David Lu, Jin H Park, Michelle DeVeaux, Xiaoling Song, Scott Gettinger, Daniel Zelterman, Mark A Lemmon, Sarah B Goldberg, Katerina Politi

Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer

HLA I 类抗原加工和呈递受损是肺癌获得性免疫检查点抑制剂耐药的机制

Scott Gettinger, Jungmin Choi, Katherine Hastings, Anna Truini, Ila Datar, Ryan Sowell, Anna Wurtz, Weilai Dong, Guoping Cai, Mary Ann Melnick, Victor Y Du, Joseph Schlessinger, Sarah B Goldberg, Anne Chiang, Miguel F Sanmamed, Ignacio Melero, Jackeline Agorreta, Luis M Montuenga, Richard Lifton, So

High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma

雷帕霉素靶标的高表达与早期肺腺癌患者的更好预后相关

Valsamo K Anagnostou, Gerold Bepler, Konstantinos N Syrigos, Lynn Tanoue, Scott Gettinger, Robert J Homer, Daniel Boffa, Frank Detterbeck, David L Rimm